Autor: |
Lau SKP; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong.; Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong., He Z; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong., Lin KPK; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong., Woo PCY; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong.; Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong. |
Abstrakt: |
Competing Interests: Conflicts of interest: Patrick C.Y. Woo has provided scientific advisory/laboratory service for Gilead Sciences, Inc., International Health Management Associates, Inc./Pfizer, Inc., and Merck & Co, Inc. All other authors have no potential competing interest. |